Invention Grant
- Patent Title: Use of zinc and copper gluconate in the treatment of methicillin-resistant Staphylococcus aureus
-
Application No.: US15557068Application Date: 2016-03-11
-
Publication No.: US10645953B2Publication Date: 2020-05-12
- Inventor: Jens Jorgen Pedersen
- Applicant: Jens Jorgen Pedersen
- Applicant Address: DK Taars US CA Porterville
- Assignee: DANTRACE-DANFEED IVS,Distributors Processing, Inc.
- Current Assignee: DANTRACE-DANFEED IVS,Distributors Processing, Inc.
- Current Assignee Address: DK Taars US CA Porterville
- Agency: Trojan Law Offices
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@6d5e7027
- International Application: PCT/DK2016/050069 WO 20160311
- International Announcement: WO2016/141946 WO 20160915
- Main IPC: A23K20/20
- IPC: A23K20/20 ; A23K20/105 ; A23K50/30 ; A61K33/30 ; A61K33/34 ; A61K9/00 ; A61P31/04 ; A61K33/32 ; A61K9/14 ; A61K9/20
Abstract:
The present invention relates to the use of zinc and copper gluconate in the treatment of methicillin-resistant Staphylococcus aureus and dietary supplements for mammals comprising zinc and copper gluconate and their use in treatment of methicillin-resistant Staphylococcus aureus.
Public/Granted literature
- US20190110499A1 USE OF ZINC AND COPPER GLUCONATE IN THE TREATMENT OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS Public/Granted day:2019-04-18
Information query
